Login to Your Account



Earnings Roundup


Tuesday, April 30, 2013
• Auxilium Pharmaceuticals Inc. of Chesterbrook, Pa., reported net revenues of $66.2 million for the first quarter ending March 31, compared to net revenues of $73.6 million in the first quarter of 2012. The decrease was attributed to a fall in U.S. sales of Xiaflex (collagenase clostridium histolyticum, or CCH) and Testim. On a U.S. GAAP basis, Auxilium reported net loss of $8.2 million, or 17 cents per share, compared to a net loss of $1.7 million, or 4 cents per share, in the same period a year earlier.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription